Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xeris Pharmaceuticals Inc (XERS) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xeris Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1346302.
Total stock buying since 2018: $30,342,150.
Total stock sales since 2018: $3,097,694.
Total stock option exercises since 2018: $18,706.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 30,000 | $158,030 | 0 | $0 |
| 2020 | 124,983 | $450,240 | 10,000 | $54,990 | 0 | $0 |
| 2019 | 644,435 | $6,391,890 | 183,530 | $2,635,937 | 0 | $0 |
| 2018 | 1,566,668 | $23,500,020 | 15,720 | $248,737 | 15,720 | $18,706 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-04 | 0 | $0 | 10,000 | $40,730 | 0 | $0 |
| 2021-01 | 0 | $0 | 20,000 | $117,300 | 0 | $0 |
| 2020-12 | 10,000 | $40,550 | 0 | $0 | 0 | $0 |
| 2020-05 | 62,886 | $202,209 | 0 | $0 | 0 | $0 |
| 2020-03 | 4,000 | $7,880 | 0 | $0 | 0 | $0 |
| 2020-02 | 48,097 | $199,601 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 10,000 | $54,990 | 0 | $0 |
| 2019-11 | 17,935 | $153,290 | 0 | $0 | 0 | $0 |
| 2019-10 | 0 | $0 | 10,000 | $79,750 | 0 | $0 |
| 2019-07 | 0 | $0 | 10,000 | $123,690 | 0 | $0 |
| 2019-04 | 0 | $0 | 10,000 | $95,650 | 0 | $0 |
| 2019-03 | 30,000 | $273,600 | 0 | $0 | 0 | $0 |
| 2019-02 | 596,500 | $5,965,000 | 22,048 | $331,695 | 0 | $0 |
| 2019-01 | 0 | $0 | 131,482 | $2,005,152 | 0 | $0 |
| 2018-12 | 0 | $0 | 15,720 | $248,737 | 15,720 | $18,706 |
| 2018-06 | 1,566,668 | $23,500,020 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-04-12 | Prestrelski Steven (Chief Scientific Officer) | Sale | 10,000 | 4.07 | 40,730 |
| 2021-01-13 | Prestrelski Steven (Chief Scientific Officer) | Sale | 10,000 | 6.01 | 60,060 |
| 2021-01-11 | Prestrelski Steven (Chief Scientific Officer) | Sale | 10,000 | 5.72 | 57,240 |
| 2020-12-09 | Edick Paul R (See Remarks) | Buy | 10,000 | 4.05 | 40,550 |
| 2020-05-13 | Shannon John Patrick Jr (See Remarks) | Buy | 22,000 | 3.54 | 77,990 |
| 2020-05-08 | Shannon John Patrick Jr (See Remarks) | Buy | 7,886 | 3.20 | 25,219 |
| 2020-05-08 | Edick Paul R (See Remarks) | Buy | 33,000 | 3.00 | 99,000 |
| 2020-03-13 | Hecht Beth (See Remarks) | Buy | 4,000 | 1.97 | 7,880 |
| 2020-02-14 | Johnson Kenneth Erland (See Remarks) | Buy | 2,410 | 4.15 | 10,001 |
| 2020-02-14 | Hecht Beth (See Remarks) | Buy | 4,000 | 4.15 | 16,600 |
| 2020-02-14 | Shannon John Patrick Jr (See Remarks) | Buy | 12,048 | 4.15 | 49,999 |
| 2020-02-14 | Edick Paul R (See Remarks) | Buy | 20,000 | 4.15 | 83,000 |
| 2020-02-14 | Deutsch Barry M. (See Remarks) | Buy | 9,639 | 4.15 | 40,001 |
| 2020-01-13 | Prestrelski Steven (Chief Scientific Officer) | Sale | 10,000 | 5.50 | 54,990 |
| 2019-11-25 | Edick Paul R (See Remarks) | Buy | 17,935 | 8.55 | 153,290 |
| 2019-10-11 | Prestrelski Steven (Chief Scientific Officer) | Sale | 10,000 | 7.97 | 79,750 |
| 2019-07-11 | Prestrelski Steven (Chief Scientific Officer) | Sale | 10,000 | 12.37 | 123,690 |
| 2019-04-11 | Prestrelski Steven (Chief Scientific Officer) | Sale | 10,000 | 9.56 | 95,650 |
| 2019-03-11 | Edick Paul R (See Remarks) | Buy | 30,000 | 9.12 | 273,600 |
| 2019-02-19 | Johnson Kenneth Erland (See Remarks) | Buy | 1,000 | 10.00 | 10,000 |
| 2019-02-19 | Hecht Beth (See Remarks) | Buy | 2,500 | 10.00 | 25,000 |
| 2019-02-19 | Green Jeremy | Buy | 588,000 | 10.00 | 5,880,000 |
| 2019-02-19 | Deutsch Barry M. (See Remarks) | Buy | 5,000 | 10.00 | 50,000 |
| 2019-02-11 | Deerfield Private Design Fund Iii, L.p. | Sale | 1,351 | 15.00 | 20,265 |
| 2019-02-08 | Deerfield Private Design Fund Iii, L.p. | Sale | 5,890 | 15.11 | 88,986 |
| 2019-02-07 | Deerfield Private Design Fund Iii, L.p. | Sale | 9,409 | 15.00 | 141,135 |
| 2019-02-06 | Deerfield Private Design Fund Iii, L.p. | Sale | 400 | 15.00 | 6,000 |
| 2019-02-05 | Deerfield Private Design Fund Iii, L.p. | Sale | 4,998 | 15.07 | 75,309 |
| 2019-01-29 | Deerfield Private Design Fund Iii, L.p. | Sale | 6,210 | 15.14 | 94,025 |
| 2019-01-28 | Deerfield Private Design Fund Iii, L.p. | Sale | 828 | 15.00 | 12,420 |
| 2019-01-25 | Deerfield Private Design Fund Iii, L.p. | Sale | 76,820 | 15.08 | 1,158,291 |
| 2019-01-24 | Deerfield Private Design Fund Iii, L.p. | Sale | 5,425 | 15.04 | 81,564 |
| 2019-01-23 | Deerfield Private Design Fund Iii, L.p. | Sale | 32,199 | 16.35 | 526,389 |
| 2019-01-14 | Prestrelski Steven (Chief Scientific Officer) | Sale | 7,700 | 17.20 | 132,463 |
| 2019-01-11 | Prestrelski Steven (Chief Scientific Officer) | Sale | 2,300 | .00 | 0 |
| 2018-12-26 | Prestrelski Steven (Chief Scientific Officer) | Sale | 15,720 | 15.82 | 248,737 |
| 2018-12-24 | Prestrelski Steven (Chief Scientific Officer) | Option Ex | 15,720 | 1.19 | 18,706 |
| 2018-06-25 | Palmetto Partners 2015, Lp (10% Owner) | Buy | 150,000 | 15.00 | 2,250,000 |
| 2018-06-25 | Green Jeremy | Buy | 666,668 | 15.00 | 10,000,020 |
| 2018-06-25 | Deerfield Private Design Fund Iii, L.p. | Buy | 750,000 | 15.00 | 11,250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of XERS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xeris Pharmaceuticals Inc (symbol XERS, CIK number 1346302) see the Securities and Exchange Commission (SEC) website.